1. All Products
  2. DRV eq. 400mg base / r 50mg, tab.
Public Pricelist

DRV eq. 400mg base / r 50mg, tab.

https://medicalguidelines.msf.org/en/node/389
https://unicat.msf.org/cat/product/85276
STD DORADRVR45T

Valid Article

6.4.2.3 - Protease inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR26
Anatomical Therapeutic Chemical Classification according to WHOCC
P
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

DARUNAVIR (DRV) / RITONAVIR (r)

Therapeutic Action

Fixed-dose combination (FDC) of two antiretrovirals, protease inhibitors (PI)

Indications

Third-line antiretroviral therapy (ART) regimen

Indicated in HIV patients after failure of a previous lopinavir/ritonavir-based ART regimen.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The fixed-dose combination (FDC) is the preferred option. It replaces the regular tablets of darunavir and ritonavir.

Precautions for Use

Darunavir in combination with ritonavir reduces the efficacy of implants and oral contraceptives: use injectable medroxyprogesterone or an intrauterine device.

Storage

Below 25ºC